These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 25706130)

  • 1. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
    Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
    PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
    Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
    BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
    JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
    Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
    Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
    Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
    Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
    Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.
    Shigehara K; Yokomuro S; Ishibashi O; Mizuguchi Y; Arima Y; Kawahigashi Y; Kanda T; Akagi I; Tajiri T; Yoshida H; Takizawa T; Uchida E
    PLoS One; 2011; 6(8):e23584. PubMed ID: 21858175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
    Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
    Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
    Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
    Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
    Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.
    Høgdall D; O'Rourke CJ; Larsen FO; Zarforoushan S; Christensen TD; Ghazal A; Boisen MK; Muñoz-Garrido P; Johansen JS; Andersen JB
    J Hepatol; 2022 Oct; 77(4):1047-1058. PubMed ID: 35750139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.
    Yoshida M; Yukawa H; Hayashi K; Naitoh I; Miyabe K; Hori Y; Natsume M; Jinno N; Kato A; Kachi K; Asano G; Sahashi H; Toyohara T; Kuno K; Kito Y; Kondo H; Hirano A; Okumura F; Anbe K; Baba Y; Kataoka H; Tanaka Y
    Cancer Sci; 2023 Jan; 114(1):295-305. PubMed ID: 36168845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.